{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:23Z","timestamp":1791895643799,"version":"4.3.4"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>We aimed to evaluate the change in bone mineral density (BMD) in patients with prostate cancer (PCa) receiving androgen deprivation therapy (ADT) compared to those with PCa or other urologic conditions not receiving ADT. Literature searches were conducted throughout October 2018. The eligibility of each study was assessed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines using the Participant, Intervention, Comparator, Outcome, and Study design method. The outcomes analyzed were the mean difference (MD) of percent changes in BMD of lumbar spine, femur neck, and total hip. Five prospective cohort studies with a total of 533 patients were included in the present study. Statistically significant decreases of BMD change relative to the control group were observed in the ADT treatment group in the lumbar spine (MD \u22123.60, 95% CI \u22126.72 to \u22120.47, P = 0.02), femoral neck (MD \u22123.11, 95% CI \u22124.73 to \u22121.48, P = 0.0002), and total hip (MD \u22121.59, 95% CI \u22122.99 to \u22120.19, P = 0.03). There is a significant relationship between ADT and BMD reduction in patients with PCa. Regular BMD testing and the optimal treatment for BMD loss should, therefore, be considered in patients with PCa undergoing ADT.<\/jats:p>","DOI":"10.3390\/jcm8010113","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T05:41:08Z","timestamp":1547790068000},"page":"113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-8756","authenticated-orcid":false,"given":"Do Kyung","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 06273, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-1767","authenticated-orcid":false,"given":"Joo Yong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Joon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-4619","authenticated-orcid":false,"given":"Yoon Soo","family":"Hah","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 06273, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Chul","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 06273, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Heon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul 04401, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-8833","authenticated-orcid":false,"given":"Kang Su","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul 06273, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bonekey.2015.85","article-title":"Androgen-deprivation therapy and bone loss in prostate cancer patients: A clinical review","volume":"4","author":"Bienz","year":"2015","journal-title":"Bonekey Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5489\/cuaj.117","article-title":"Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: Incorporating new agents into clinical practice","volume":"6","author":"So","year":"2012","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3349\/ymj.2018.59.5.567","article-title":"Treatment of oligometastatic hormone-sensitive prostate cancer: A comprehensive review","volume":"59","author":"Koo","year":"2018","journal-title":"Yonsei Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"Prostate cancer, version 1.2016","volume":"14","author":"Mohler","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.juro.2006.08.089","article-title":"Bone health in men receiving androgen deprivation therapy for prostate cancer","volume":"177","author":"Eastham","year":"2007","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3349\/ymj.2018.59.5.580","article-title":"Impact of early salvage androgen deprivation therapy in localized prostate cancer after radical prostatectomy: A propensity score matched analysis","volume":"59","author":"Park","year":"2018","journal-title":"Yonsei Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/00365590310018810","article-title":"Changes in bone mineral density differ between gonadotrophin-releasing hormone analogue- and surgically castrated men with prostate cancer\u2014A prospective, controlled, parallel-group study","volume":"38","author":"Bergstrom","year":"2004","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","article-title":"Progressive osteoporosis during androgen deprivation therapy for prostate cancer","volume":"163","author":"Daniell","year":"2000","journal-title":"J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1464-410X.2003.04471.x","article-title":"Immediate dual energy x-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation","volume":"92","author":"Hussain","year":"2003","journal-title":"BJU Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","article-title":"Bone loss following hypogonadism in men with prostate cancer treated with gnrh analogs","volume":"87","author":"Mittan","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0022-5347(01)61639-2","article-title":"Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma","volume":"161","author":"Maillefert","year":"1999","journal-title":"J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00298427","article-title":"Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens","volume":"57","author":"Eriksson","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00198-013-2343-4","article-title":"Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin d","volume":"24","author":"Alibhai","year":"2013","journal-title":"Osteoporos Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","article-title":"Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression","volume":"175","author":"Morote","year":"2006","journal-title":"J. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.pcan.4500599","article-title":"Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss","volume":"5","author":"Preston","year":"2002","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clgc.2012.08.005","article-title":"Complex metabolic and skeletal changes in men taking long-term androgen deprivation therapy","volume":"11","author":"Ziaran","year":"2013","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., and Stewart, L.A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015 statement. Syst. Rev., 4.","DOI":"10.1186\/2046-4053-4-1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: An update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2002-021036","article-title":"Differential effects of androgens and estrogens on bone turnover in normal men","volume":"88","author":"Leder","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1210\/jc.2002-021429","article-title":"Deterioration of trabecular architecture in hypogonadal men","volume":"88","author":"Benito","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1210\/jc.2010-0902","article-title":"Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy","volume":"95","author":"Hamilton","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R371","DOI":"10.1530\/ERC-14-0172","article-title":"Muscle and bone effects of androgen deprivation therapy: Current and emerging therapies","volume":"21","author":"Cheung","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2007.03.026","article-title":"Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy","volume":"70","author":"Ryan","year":"2007","journal-title":"Urology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: An endocrine society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.juro.2010.04.068","article-title":"Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: A matched cohort study of 19,079 men","volume":"184","author":"Alibhai","year":"2010","journal-title":"J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.3747\/co.v18i4.746","article-title":"A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy","volume":"18","author":"Lee","year":"2011","journal-title":"Curr. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2013.0215","article-title":"Nccn task force report: Bone health in cancer care","volume":"11","author":"Gralow","year":"2013","journal-title":"J. Natl. Compr. Cancar Netw."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bju.14015","article-title":"Systematic review and network meta-analysis on the relative efficacy of osteoporotic medications: Men with prostate cancer on continuous androgen-deprivation therapy to reduce risk of fragility fractures","volume":"121","author":"Poon","year":"2018","journal-title":"BJU Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-6465(22)02567-1","article-title":"Exercise in the prevention and treatment of osteoporosis: The role of physical therapy and nursing","volume":"36","author":"Hertel","year":"2001","journal-title":"Nurs. Clin. N. Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: A meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Guo, Z., Huang, Y., Gong, L., Gan, S., Chan, F.L., Gu, C., Xiang, S., and Wang, S. (2018). Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis.","DOI":"10.1038\/s41391-018-0059-4"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00520-014-2285-1","article-title":"Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis","volume":"22","author":"McGinty","year":"2014","journal-title":"Support Care Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Meng, F., Zhu, S., Zhao, J., Vados, L., Wang, L., Zhao, Y., Zhao, D., and Niu, Y. (2016). Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2221-5"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"Grade guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/1\/113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:27:02Z","timestamp":1760185622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/1\/113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["jcm8010113"],"URL":"https:\/\/doi.org\/10.3390\/jcm8010113","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]}}}